Syneos Health US, Inc.
Syneos Health US, Inc., a leading biopharmaceutical solutions organisation, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2018 through the merger of INC Research and inVentiv Health, the company has quickly established itself in the clinical research and commercialisation sectors. Specialising in integrated biopharmaceutical solutions, Syneos Health offers a unique combination of clinical development and commercial services, enabling clients to accelerate the delivery of innovative therapies to market. Their commitment to a patient-centric approach and advanced technology sets them apart in a competitive landscape. With a strong market position, Syneos Health has achieved notable milestones, including recognition for its innovative strategies in clinical trial management and patient engagement. The company continues to drive advancements in the healthcare industry, making significant contributions to the success of its partners.
DitchCarbon Score
How does Syneos Health US, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Syneos Health US, Inc.'s score of 31 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Syneos Health US, Inc.'s reported carbon emissions
Syneos Health US, Inc. currently does not have publicly available carbon emissions data or specific reduction targets outlined in their climate commitments. Without emissions data, it is challenging to assess their current carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the company may be engaged in various sustainability initiatives typical within the industry, focusing on reducing environmental impact and enhancing climate resilience. As the landscape of corporate climate commitments evolves, it is essential for organisations like Syneos Health to establish measurable targets and transparent reporting to align with global climate goals. For a comprehensive understanding of their climate strategy, further details on their initiatives and commitments would be necessary.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Syneos Health US, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
